Bowel cancer audit

Bowel cancer audit
Name	Bowel cancer audit
Type	Clinical audit
Location	United Kingdom
Focus	Colorectal cancer care quality

Bowel cancer audit is a national clinical audit programme that evaluates the quality of care for patients with colorectal cancer across hospitals and trusts in England and Wales, aiming to improve outcomes through data-driven quality improvement. The audit informs clinicians, health services, commissioning bodies and patient groups by benchmarking performance against standards set by professional bodies and national policy frameworks.

Overview

The audit collects patient-level data on diagnosis, staging, treatment, outcomes and multidisciplinary team processes, providing comparative reports used by the National Health Service (England), NHS Wales, Royal College of Surgeons of England, Association of Coloproctology of Great Britain and Ireland, Cancer Research UK and other stakeholders to guide service improvement. It links clinical activity to outcome measures such as 30‑day mortality, postoperative complications, long-term survival and adherence to guideline-recommended pathways promoted by organisations including the National Institute for Health and Care Excellence, Clinical Commissioning Groups, Public Health England and specialist charities like Macmillan Cancer Support. The audit feeds into national reports, commissioning decisions and research collaborations with academic centres such as University of Oxford, University College London, University of Cambridge, Imperial College London and cancer networks across regions including the Northern Cancer Network and London Cancer.

History and development

The audit originated from initiatives in the late 20th and early 21st century to standardise cancer outcomes monitoring, drawing on precedents such as the National Hip Fracture Database, the National Vascular Registry and the National Lung Cancer Audit. Early development involved partnerships between professional bodies like the Royal College of Physicians, regulatory agencies including the Care Quality Commission and policy units within the Department of Health and Social Care. Significant milestones include the publication of initial national reports, integration with cancer registry datasets managed by organisations such as the Office for National Statistics and the gradual expansion of dataset scope after consultations with trusts, specialist societies and patient groups represented by organisations like Healthwatch England and Age UK. Influential figures and committees from surgical and oncology communities at centres such as The Royal Marsden and St Mark's Hospital helped shape dataset definitions and audit governance.

Methodology and data collection

Data collection uses standardised data dictionaries aligned with coding systems maintained by bodies such as NHS Digital and diagnostic classifications like the International Classification of Diseases administered by the World Health Organization. Reporting hospitals submit anonymised case-level data on demographics, tumour site, TNM stage, imaging modalities, operative approach, adjuvant therapy and follow-up; linkage with datasets from the National Cancer Registration and Analysis Service, Hospital Episode Statistics and mortality records from the Office for National Statistics enables outcome ascertainment. The audit employs statistical risk adjustment and funnel plot methods grounded in techniques from academic groups at London School of Hygiene & Tropical Medicine and University of Bristol to produce provider-level benchmarking, while steering committees with representatives from the Royal College of Surgeons of England and Association of Coloproctology of Great Britain and Ireland oversee clinical definitions and data quality. Data security and governance align with standards set by the Health Research Authority and information governance frameworks within NHS England.

Key findings and impact on clinical practice

Findings have documented variation in perioperative mortality, rates of emergency presentation, use of laparoscopic surgery, and adherence to multidisciplinary team recommendations, prompting targeted quality improvement programmes and training initiatives at surgical centres such as Addenbrooke's Hospital, Guy's and St Thomas' NHS Foundation Trust and Leeds Teaching Hospitals NHS Trust. Reports influenced national policy on screening and referral pathways alongside campaigns led by organisations like NHS England and Cancer Research UK, contributing to increased uptake of bowel screening using faecal immunochemical tests recommended by the National Institute for Health and Care Excellence and shaping surgical performance metrics used by regulators including the Care Quality Commission. Academic analyses using audit data have appeared in journals affiliated with institutions such as The Lancet, BMJ, Journal of Clinical Oncology and research groups at University of Glasgow and Newcastle University, informing guideline updates by professional bodies including the Association of Coloproctology of Great Britain and Ireland and the Royal College of Surgeons of England.

Governance, funding and reporting

Governance structures typically include clinical leads, methodological advisers and patient representatives drawn from organisations like Macmillan Cancer Support and Patient Information Forum, operating under contractual arrangements with statutory bodies such as NHS England and commissioning through networks including Integrated Care Systems. Funding sources combine public funding from health departments, grants from charities such as Cancer Research UK and in‑kind support from professional colleges; reporting cycles produce annual and thematic reports disseminated to trusts, commissioners and national bodies including the National Cancer Research Institute. Data access for research is managed through application processes consistent with approvals from the Health Research Authority and local research and development offices at university hospitals.

Criticisms and limitations

Criticisms include incomplete data submission by some providers, potential coding inconsistencies relative to standards promoted by NHS Digital, residual confounding despite risk adjustment methods developed in academic centres like University of Leeds and concerns about public reporting leading to unintended behaviour by clinicians studied in health policy debates at King's Fund and Nuffield Trust. Limitations also involve time lags between care episode and publication, challenges linking to evolving datasets held by agencies like the National Cancer Registration and Analysis Service, and difficulties in capturing patient-reported outcomes emphasised by patient charities such as Macmillan Cancer Support and Marie Curie.

Category:Colorectal cancer